Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Surveillance Protocols for Survivors at Risk for Lymphedema

Surveillance Protocols for Survivors at Risk for Lymphedema Purpose of ReviewBreast cancer treatments introduce risk for developing lymphedema. There are identifiable tissue and sensory changes that are associated with the onset of breast cancer–related lymphedema (BCRL) that can enhance early identification and treatment of the condition. Therefore, there exists an unprecedented opportunity to employ surveillance protocols to monitor for the earliest signs and symptoms of the condition.Recent FindingsStandardized methods for prospective surveillance have been investigated and show effectiveness in promoting early identification and early management of BCRL. Furthermore, there is emerging evidence that this approach can support broad assessment of physical function for individuals with breast cancer, improving quality of life and potentially reducing cost associated with treatment-related morbidity.SummaryThis article provides an overview of the prospective surveillance model (PSM), an optimal framework for early identification of BCRL in individuals at risk, shares implementation strategies across two different cultures, and suggests future direction for research and clinical practice to enhance implementation. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Breast Cancer Reports Springer Journals

Surveillance Protocols for Survivors at Risk for Lymphedema

Download PDF
9 pages

Loading next page...
 
/lp/springer-journals/surveillance-protocols-for-survivors-at-risk-for-lymphedema-T0wkJUWnxu

References (80)

Publisher
Springer Journals
Copyright
Copyright © The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature 2021
ISSN
1943-4588
eISSN
1943-4596
DOI
10.1007/s12609-020-00402-y
Publisher site
See Article on Publisher Site

Abstract

Purpose of ReviewBreast cancer treatments introduce risk for developing lymphedema. There are identifiable tissue and sensory changes that are associated with the onset of breast cancer–related lymphedema (BCRL) that can enhance early identification and treatment of the condition. Therefore, there exists an unprecedented opportunity to employ surveillance protocols to monitor for the earliest signs and symptoms of the condition.Recent FindingsStandardized methods for prospective surveillance have been investigated and show effectiveness in promoting early identification and early management of BCRL. Furthermore, there is emerging evidence that this approach can support broad assessment of physical function for individuals with breast cancer, improving quality of life and potentially reducing cost associated with treatment-related morbidity.SummaryThis article provides an overview of the prospective surveillance model (PSM), an optimal framework for early identification of BCRL in individuals at risk, shares implementation strategies across two different cultures, and suggests future direction for research and clinical practice to enhance implementation.

Journal

Current Breast Cancer Reports – Springer Journals

Published: Jan 7, 2021

There are no references for this article.